Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for the 2021 plan year, the Centers for Medicare & Medicaid Services said yesterday.

Announced in March, the five-year model will require participating plans to limit cost sharing for a 30-day supply of insulin to no more than $35. CMS estimates beneficiaries in the plans could save an average $446 (66%) in out-of-pocket costs for insulin, funded in part by manufacturer discounts. Part D sponsors that applied must submit their calendar year 2021 plan benefits to CMS by June 1. CMS expects to release CY 2021 premiums and costs for specific Medicare plans in September, including final information on the model.

Related News Articles

Headline
The AHA Jan. 31 commended Sens. Bill Cassidy, R-La., Catherine Cortez Masto, D-Nev., John Cornyn, R-Texas., and Michael Bennet, D-Colo., on draft legislation…
Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
An analysis by KFF released Jan. 28 found that Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023. The finding…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The AHA Jan. 27 voiced support for the Centers for Medicare & Medicaid Services proposed rule on policy and technical changes to Medicare Advantage and…
Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will…